Pelvic Pain in Men with Mycoplasma Genitalium
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: There are debates about Mycoplasma genitalium (M. genitalium) causing prostate infection and inducing pelvic pains. Consequently, M. genitalium-associated pelvic pains were characterized and their manifestation in male pelvic pain syndrome (MPPS) was evaluated through a case-control study. Materials and Methods: The presence of M. genitalium-associated pelvic pains was examined in 113 M. genitalium-infected men, and the typical presentations of mycoplasma-associated MPPS were characterized through a case-control study involving 80 mycoplasma-infected and 234 case-matched uninfected controls. Finally, changes in symptoms following antimicrobial treatments were compared between 27 cured and 14 persistently infected cases. Results: Pain locations from 113 men were followed as items-1a for 25.7%, 1b for 21.2%, 1c for 31%, 1d for 18.6%, 2a for 59.3%, and 2b for 23% from the Korean National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) questionnaire. In addition, the sum scores from the pain domain, voiding domain and total score were 6.68±4.75, 2.69±2.66, and 15.00±8.66, respectively. Successful antibiotic therapy significantly reduced the total score from baseline (15.148±6.798 vs. 5.357±7.025, p=0.001). From the case-control study, mycoplasma-infected men had pains more frequently during urination (1c) and on the tip of the penis (2a) (all p=0.0001) than the controls. Conclusions: It was found that M. genitalium infection is associated with clinically significant male pelvic pains, which improved with adequate antimicrobial therapies. Urethral irritation symptoms without pyuria may be the typical characteristics of mycoplasma-associated pelvic pains in MPPS.
Abstract
Purpose: There are debates about Mycoplasma genitalium (M. genitalium) causing prostate infection and inducing pelvic pains. Consequently, M. genitalium-associated pelvic pains were characterized and their manifestation in male pelvic pain syndrome (MPPS) was evaluated through a case-control study. Materials and Methods: The presence of M. genitalium-associated pelvic pains was examined in 113 M. genitalium-infected men, and the typical presentations of mycoplasma-associated MPPS were characterized through a case-control study involving 80 mycoplasma-infected and 234 case-matched uninfected controls. Finally, changes in symptoms following antimicrobial treatments were compared between 27 cured and 14 persistently infected cases. Results: Pain locations from 113 men were followed as items-1a for 25.7%, 1b for 21.2%, 1c for 31%, 1d for 18.6%, 2a for 59.3%, and 2b for 23% from the Korean National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI) questionnaire. In addition, the sum scores from the pain domain, voiding domain and total score were 6.68±4.75, 2.69±2.66, and 15.00±8.66, respectively. Successful antibiotic therapy significantly reduced the total score from baseline (15.148±6.798 vs. 5.357±7.025, p=0.001). From the case-control study, mycoplasma-infected men had pains more frequently during urination (1c) and on the tip of the penis (2a) (all p=0.0001) than the controls. Conclusions: It was found that M. genitalium infection is associated with clinically significant male pelvic pains, which improved with adequate antimicrobial therapies. Urethral irritation symptoms without pyuria may be the typical characteristics of mycoplasma-associated pelvic pains in MPPS.
참고문헌 (23)
- chronic pelvic pain syndrome, "Chronic prostatitis", pp.2008, Nguyen C
- Dallo SF, "Intracellular DNA replication and long-term survival of pathogenic mycoplasmas", Microb Pathog, 29, pp.301~309 (2000)
- McGowin CL, "Intracellular Mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing", BMC Microbiol, 9, pp.139~ (2009)
- Nasralla M, "Multiple mycoplasmal infections detected in blood of patients with chronic fatigue syndrome and", or fibromyalgia syndrome, 1999, pp.18, 859~865
- Lis R, "Mycoplasma genitalium infection and female reproductive tract disease : a meta-analysis", Clin Infect Dis, 61, pp.418~426 (2015)
- Cina M, "Mycoplasma genitalium incidence, persistence, concordance between partners and progression : systematic review and meta-analysis", Sex Transm Infect, 95, pp.328~335 (2019)
- Ito S, "Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years-of-age with acute epididymitis", Int J Urol, 19, pp.234~238 (2012)
- Jensen JS, "2021 European guideline on the management of Mycoplasma genitalium infections", J Eur Acad Dermatol Venereol, 36, pp.641~650 (2022)
- Mo X, "Prevalence and correlates of Mycoplasma genitalium infection among prostatitis patients in Shanghai, China", Sex Health, 13, pp.474~479 (2016)
- Mandar R, "Mycoplasmas in semen of chronic prostatitis patients", Scand J Urol Nephrol, 39, pp.479~482 (2005)
- Workowski KA, "Sexually transmitted infections treatment guidelines, 2021", MMWR Recomm Rep, 70, pp.1~187 (2021)
- Krieger JN, "Prokaryotic DNA sequences in patients with chronic idiopathic prostatitis", J Clin Microbiol, 34, pp.3120~3128 (1996)
- chronic pelvic pain syndrome, "Chronic prostatitis", pp.2008, Weidner W
- Seo Y, "mgpB genotyping and genetic diversity for antimicrobial resistance of Mycoplasma genitalium", J Med Microbiol, 71 (2022)
- Park H, "The presence of Chlamydia is associated with increased leukocyte counts and pain severity in men with chronic pelvic pain syndrome", Urology, 85, pp.574~579 (2015)
- Litwin MS, "The National Institutes of Health chronic prostatitis symptom index : development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network", J Urol, 162, pp.369~375 (1999)
- Schaeffer AJ, "Epidemiology and evaluation of chronic pelvic pain syndrome in men", Int J Antimicrob Agents, 31(Suppl 1), pp.S108~S111 (2008)
- Jensen JS, "Use of TaqMan 5'nuclease real-time PCR for quantitative detection of Mycoplasma genitalium DNA in males with and without urethritis who were attendees at a sexually transmitted disease clinic", J Clin Microbiol, 42, pp.683~692 (2004)
- Seo Y, "Molecular mechanisms of macrolide and fluoroquinolone resistance among Korean isolates of Mycoplasma genitalium over a period of five years 2014-2019", J Med Microbiol, 70 (2021)
- Nickel JC, "Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index", J Urol, 165, pp.842~845 (2001)
- Clemens JQ, "Rescoring the NIH chronic prostatitis symptom index : nothing new", Prostate Cancer Prostatic Dis, 12, pp.285~287 (2009)
- Propert KJ, "Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)", Qual Life Res, 15, pp.299~305 (2006)
- Cole JA, "Reducing selection bias in case-control studies from rare disease registries", Orphanet J Rare Dis, 6, pp.61~ (2011)